Health
The reasons why regulators aren’t greenlighting existing medical treatments that show promise for coronavirus – ABC News
There are existing medications and treatments that seem to show some promise and have already been evaluated for safety. So why not just greenlight these? What are the potential downsides to this approach?
Aspirin was originally developed as a painkiller, but now many people take it every day to prevent heart disease.
Scientists are taking a similar approach in their hunt to find medications to treat coronavirus: looking for drugs already approved for use in managing certain conditions that show promise in treating COVID-19.
Using a repurposed drug is the easiest path to take when looking for a new medical treatment, explains infectious diseases expert Sharon Lewin, director of the Peter Doherty…
-
Business19 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General24 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News19 hours agoQueensland’s nurses and midwives ramp up industrial action as pay negotiations break down
-
Noosa News20 hours agoBroncos staffer who guided Mam through crash crisis admits to drink-driving